Nursing management of targeted therapies for ErbB2 positive breast cancer:  developing a quality service

dc.contributor.author	Depledge, J
dc.date.accessioned	2012-07-18T11:22:39Z
dc.date.available	2012-07-18T11:22:39Z
dc.date.issued	2012-07-18
dc.identifier.uri	http://hdl.handle.net/123456789/766
dc.description.abstract	EGFR Inhibitors in Metastatic Breast Cancer, Glaxo Smith Kline, Stockley Park West, Uxbridge. 15-17 October 2008, Advisory panel member and delivery of a module presentation	en_US
dc.subject	Nursing	en_US
dc.subject	breast cancer	en_US
dc.subject	cancer	en_US
dc.subject	service	en_US
dc.subject	therapies	en_US
dc.title	Nursing management of targeted therapies for ErbB2 positive breast cancer: developing a quality service	en_US
dc.type	Other	en_US